Evidence map›Paper›PMID 35058270›Full record

ArticleBMJ open2022

Proportionate translation of study materials and measures in a multinational global health trial: methodology development and implementation.

Ashleigh Charles, Palak Korde, Chris Newby, Alina Grayzman, Ramona Hiltensperger, Candelaria Mahlke, Galia Moran, Juliet Nakku, Jackie Niwemuhwezi, Rebecca Nixdorf and 7 more

Abstract read
In one paragraph

Article in BMJ open, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Ashleigh CharlesSchool of Health Sciences, Institute of Mental Health, University of Nottingham, Nottingham, UK Ashleigh.charles@nottingham.ac.uk.ORCID 0000-0003-2222-4358
Palak KordeCentre for Mental Health Law and Policy, Indian Law Society, Pune, Maharashtra, India.
Chris NewbySchool of Medicine, University of Nottingham, Nottingham, UK.ORCID 0000-0002-2936-8592
Alina GrayzmanDepartment of Social Work, Ben Gurion University of the Negev, Be'er Sheva, Israel.
Ramona HiltenspergerDepartment of Psychiatry II, Ulm University, Ulm, Germany.ORCID 0000-0003-2544-4188
Candelaria MahlkeDepartment of Psychiatry, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.ORCID 0000-0001-9573-6106
Galia MoranDepartment of Social Work, Ben Gurion University of the Negev, Be'er Sheva, Israel.ORCID 0000-0001-9718-1773
Juliet NakkuButabika National Referral Hospital, Kampala, Uganda.ORCID 0000-0002-0611-1102
Jackie NiwemuhweziButabika National Referral Hospital, Kampala, Uganda.
Rebecca NixdorfDepartment of Psychiatry, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.ORCID 0000-0002-3064-8380
Eva PaulDepartment of Psychiatry II, Ulm University, Ulm, Germany.ORCID 0000-0002-5827-0578
Bernd PuschnerDepartment of Psychiatry II, Ulm University, Ulm, Germany.ORCID 0000-0002-2929-4271
Mary RameshDepartment of Health Systems, Impact Evaluation and Policy, Ifakara Health Institute, Ifakara, Morogoro, United Republic of Tanzania.
Grace Kathryn RyanCentre for Global Mental Health, London School of Hygiene and Tropical Medicine, London, UK.ORCID 0000-0002-9310-3513
Donat ShambaDepartment of Health Systems, Impact Evaluation and Policy, Ifakara Health Institute, Ifakara, Morogoro, United Republic of Tanzania.ORCID 0000-0001-7431-7199
Jasmine KalhaCentre for Mental Health Law and Policy, Indian Law Society, Pune, Maharashtra, India.ORCID 0000-0001-7357-2366
Mike SladeSchool of Health Sciences, Institute of Mental Health, University of Nottingham, Nottingham, UK.ORCID 0000-0001-7020-3434

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesCurrent translation guidelines do not include sufficiently flexible translation approaches for different study materials. We aimed to develop a proportionate methodology to inform translation of all types of study materials in global health trials.

designThe design included three stages: (1) categorisation of study materials, (2) integration of existing translation frameworks and (3) methodology implementation (Germany, India, Israel, Tanzania and Uganda) and refinement.

participantsThe study population comprised 27 mental health service users and 27 mental health workers who were fluent in the local language in stage 7 (pretesting), and 54 bilingual mental health service users, aged 18 years or over, and able to give consent as judged by a clinician for step 9 (psychometric evaluation).

settingThe study took place in preparation for the Using Peer Support in Developing Empowering Mental Health Services (UPSIDES) randomised controlled trial (ISRCTN26008944). PRIMARY OUTCOME MEASURE: The primary outcome measure was the Social Inclusion Scale (SIS).

resultsThe typology identifies four categories of study materials: local text, study-generated text, secondary measures and primary measure. The UPSIDES Proportionate Translation Methodology comprises ten steps: preparation, forward translation, reconciliation, back translation, review, harmonisation, pretesting, finalisation, psychometric evaluation and dissemination. The translated primary outcome measure for the UPSIDES Trial (SIS) demonstrated adequate content validity (49.3 vs 48.5, p=0.08), convergent validity and internal consistency (0.73), with minimal floor/ceiling effects.

conclusionThis methodology can be recommended for translating, cross-culturally adapting and validating all study materials, including standardised measures, in future multisite global trials. The methodology is particularly applicable to multi-national studies involving sites with differing resource levels. The robustness of the psychometric findings is limited by the sample sizes for each site. However, making this limitation explicit is preferable to the typical practice of not reporting adequate details about measure translation and validation. TRAIL REGISTRATION NUMBER: ISRCTN26008944.

Indexed as

Global HealthMental Health ServicesAdolescentGermanyHumansPsychometricsTranslationsMENTAL HEALTHPSYCHIATRYSTATISTICS & RESEARCH METHODS

Identifiers

PMID35058270
PMCPMC8783829

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.